Dr. May Morris | Cancer Cell Biology | Women Researcher Award
IBMM / CNRS | France
Dr. May C. Morris is a CNRS Research Director (DR2) leading the “Biosensors and Inhibitors Group” within the Cellular Pharmacology Team at IBMM, University of Montpellier. Her research focuses on cell cycle biology, cancer, kinases and phosphatases, and peptide/protein biochemistry. She specializes in biophysical studies of protein interactions, fluorescent biosensor engineering, cell-penetrating peptide technologies, intracellular targeting, and high-throughput screening of small molecules. Dr. Morris has extensive experience in designing peptide and allosteric kinase inhibitors, as well as advanced cell culture and fluorescence imaging. Her career includes leadership roles at CNRS and postdoctoral research at the Scripps Research Institute.
Citations
Documents
h-index
Featured Publications
Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells
– Journal of Cell Biology, 2022 (9 Citations)
CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation
– Molecular Oncology, 2023 (7 Citations)
Ethaverine and Papaverine Target Cyclin-Dependent Kinase 5 and Inhibit Lung Cancer Cell Proliferation and Migration
– ACS Pharmacology and Translational Science, 2024 (2 Citations)
Multiplexed Profiling of CDK Kinase Activities in Tumor Biopsies with Fluorescent Peptide Biosensors
– ACS Sensors, 2024 (2 Citations)
Visible and near infrared absorption and fluorescence studies of the adsorption and coverage of doxorubicin on single-walled carbon nanotubes
– Spectrochimica Acta Part A, 2026 (0 Citations)